Brief: Tetra Bio-Pharma And Cannvalate Enter Into Partnership
May 5 (Reuters) - Tetra Bio Pharma Inc TBP.TO :
* TETRA BIO-PHARMA AND CANNVALATE ENTER INTO PARTNERSHIP
* TETRA BIO PHARMA INC - CANNVALATE TO INVEST CAD$7.5
MILLION IN
TETRA
* TETRA BIO PHARMA INC - CANNVALATE TO LAUNCH AND MANAGE
QIXLEEF™
AND CAUMZ™ CLINICAL TRIALS IN AUSTRALIA
* TETRA BIO PHARMA INC - COMPANY TO BENEFIT FROM A 43.5% TAX
CREDIT ON ALL MONEY SPENT ON CLINICAL TRIALS IN AUSTRALIA
Source text for Eikon: ID:nPn6QpMR3a
Further company coverage: TBP.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding